Regentree LLC

2 trials 1 recruiting Commercial sponsor

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

4 Countries active

1 Unique IMPs

100% Results reported

Phase III

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Neurotrophic keratopathy 1

Top IMPs

TIMBETASIN ACETATE 2

All trials

2 total

A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RG… Recruiting

2024-518969-98-00 Phase III 3 countries TIMBETASIN ACETATE
SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of… Ended

2022-502697-16-00 Phase III 4 countries TIMBETASIN ACETATE

Showing 1–2 of 2 trials

← All sponsors A–Z